文献速递类风湿关节炎脊柱关节炎痛风与晶体性关节病

1990至2023年高收入地区肌肉骨骼疾病负担与医疗成本分析

Global and high-income regional burden and healthcare costs of musculoskeletal diseases, 1990-2023.
PubMed 文献 · Ann Rheum Dis · 2026-05-29

该研究基于全球疾病负担2023数据库,分析36个高收入国家1990至2023年肌肉骨骼疾病的发病率、患病率和伤残损失寿命年趋势,并估算2023年直接医疗成本及主要风险因素归因负担。

要点

  • 1990至2023年高收入地区肌肉骨骼疾病发病、患病和YLDs绝对数分别增长36.75%、54.28%和49.36%。
  • 高BMI归因YLDs比例从1990年8.3%升至2023年10.7%,职业人体工效学因素稳定在约7.7%。

核心结论

  • 高收入地区肌肉骨骼疾病负担持续加重,主要由老龄化、肥胖和职业因素驱动,经济发展未能缓解该负担。

研究设计与样本

  • 利用全球疾病负担2023数据库分析36个高收入国家1990至2023年肌肉骨骼疾病趋势。
  • 采用贝叶斯meta回归模型量化主要风险因素归因负担,并用跨国转移模型估算2023年直接医疗成本。

主要发现

  • 1990至2023年高收入地区肌肉骨骼疾病发病、患病和YLDs总数分别增加36.75%、54.28%和49.36%。
  • 年龄标化发病率下降4.07%,但标化患病率和YLD率分别上升5.04%和3.98%。
  • 下背痛和骨关节炎占疾病负担比例最大,除痛风外所有亚型女性负担均高于男性。
  • 高BMI归因YLDs比例从1990年8.3%升至2023年10.7%,职业人体工效学因素稳定在约7.7%,吸烟相关负担下降30%。

关键数值与推荐

  • SDI与肌肉骨骼疾病年龄标化负担率之间无显著关联。

临床怎么用

  • 未来防控应重点关注体重管理和职业人体工效学干预,以遏制疾病增长并减轻经济压力。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: This study aimed to clarify the latest epidemiologic trends, economic costs, and key drivers of musculoskeletal disorders (MSDs) in high-income regions, where the disease burden has increased despite high overall healthcare spending. METHODS: Utilising data from the Global Burden of Disease 2023 database, we analysed the trends in incidence, prevalence, and years lived with disability (YLDs) for MSD across 36 high-income countries from 1990 to 2023. Bayesian meta-regression models were employed to quantify the burden attributable to major risk factors. A cross-national transfer model was used to estimate the direct healthcare economic costs associated with MSD in 2023. Spearman correlation analysis was applied to explore the relationship between the Sociodemographic Index (SDI) and disease burden, and trends in disease burden were forecasted for the period 2024 to 2050. RESULTS: Between 1990 and 2023, the total number of incident cases, prevalent cases, and YLDs for MSD in high-income regions increased by 36.75%, 54.28%, and 49.36%, respectively. Although the age-standardised incidence rate decreased by 4.07%, the standardised prevalence and YLD rates increased by 5.04% and 3.98%, respectively, indicating a continuously growing absolute disease burden. Low back pain and osteoarthritis accounted for the largest proportion of the disease burden. For all MSD subtypes except gout, the burden was higher in females than in males. In 2023, the direct medical costs associated with MSD reached as high as $327.68 billion, with the United States accounting for >45% of this amount. Regarding risk factors, the proportion of YLDs attributable to high body mass index increased from 8.3% in 1990 to 10.7% in 2023. The contribution of occupational ergonomic factors remained stable at approximately 7.7%, whereas the smoking-related burden decreased by 30%. Correlation analysis revealed no significant association between the SDI and the age-standardised burden rates of MSD. CONCLUSIONS: The burden of MSD in high-income regions continues to intensify, driven primarily by ageing, obesity, and occupational factors, and has not been alleviated by economic development. Future prevention and control efforts should focus on weight management and occupational ergonomic interventions to curb the growth of the disease and mitigate the substantial economic pressure.

来源:Ann Rheum Dis,查看原文。版权归原作者所有。

引用

  1. Yao Y, Liu G, Vithran DTA, et al. Global and high-income regional burden and healthcare costs of musculoskeletal diseases, 1990-2023. Ann Rheum Dis. 2026. PMID: 42215374. doi:10.1016/j.ard.2026.05.001

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。